Axon discloses $80,000 in quarterly lobbying spend
Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash
Axon Enterprise disclosed $80,000 in lobbying expenditures for the third quarter of 2026, targeting legislation including the Law-Enforcement Innovate to De-Escalate Act of 2025 and the Innovate Less Lethal to De-Escalate Tax Modernization Act. Insider trading data shows significant executive sales with no purchases over the last six months. Institutional investors both added and trimmed positions, while analysts maintain an Overweight rating with a median price target of $687.00.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.